Dr Reddy's Laboratories said it aims to be among the top five drugmakers in India, largely driven by mergers and acquisitions (M&A) of brands, companies and in-licensing deals targeting chronic categories, along with broadening of nutraceutical...
Moderna Inc said on Wednesday that an updated version of its COVID-19 vaccine designed to target the Omicron variant also generated a strong immune response against the fast-spreading Omicron subvariants BA.4 and BA.5, which have gained a foothold..
AstraZeneca India, the services division of biopharmaceutical major AstraZeneca, said it has expanded the Ganga Godavari Cancer -Screening Programme to Tamil Nadu, under its corporate social responsibility...
An interim analysis of AstraZeneca and partner Ionis Pharmaceuticals' eplontersen showed the experimental drug met the main goals in a late-stage trial in patients with a rare, fatal disease, the Anglo-Swedish drugmaker said on Tuesday...
Commerce and industry minister Piyush Goyal on Monday said intellectual property rights (TRIPS) waiver for five years agreed in the recently concluded WTO meet will help developing countries manufacture patented Covid vaccines to deal...
U.S. healthcare giant Pfizer has agreed to invest 90.5 million euros ($95.24 million) to buy an 8.1% percent stake in French vaccines company , as the companies announced developments in their collaboiration to tackle the Lyme disease...
The European Medicines Agency (EMA) started a rolling review on Friday of a variant-adapted COVID-19 vaccine from Moderna, as coronavirus cases linked to Omicron sub-variants see an uptick in the region...
Pharma major Cipla Ltd on Friday said it will acquire 21.05 per cent stake for Rs 25 crore in Achira Labs Pvt Ltd, which is engaged in development and commercialisation of point of care (PoC) medical test kits in India...
Significance of respiratory devices for patients suffering from respiratory diseases and how technology plays a major role in designing the right solution.
Glenmark Pharmaceuticals Limited (Glenmark) has launched the novel fixed-dose combination (FDC) drug-Indacaterol + Mometasone for patients suffering from uncontrolled asthma in India...
, CDSCO.jpg)
